Trials / Completed
CompletedNCT02424149
Phenazopyridine for Confirmation of Ureteral Patency
Use of Phenazopyridine for Confirmation of Ureteral Patency During Intraoperative Cystoscopy
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 107 (actual)
- Sponsor
- Hartford Hospital · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
In this prospective, randomized trial subjects will be randomized to receive phenazopyridine or no medication prior to pelvic reconstructive procedures that use cystoscopy to confirm ureteral patency intraoperatively.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Phenazopyridine |
Timeline
- Start date
- 2015-04-01
- Primary completion
- 2016-01-01
- Completion
- 2016-01-01
- First posted
- 2015-04-22
- Last updated
- 2016-12-05
- Results posted
- 2016-12-05
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02424149. Inclusion in this directory is not an endorsement.